Cite
HARVARD Citation
Merz, C. et al. (n.d.). The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell–mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells. Journal of immunotherapy. 41 (9), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Merz, C. et al. (n.d.). The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell–mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells. Journal of immunotherapy. 41 (9), p. . [Online].